<<

. 12
( 51 .)



>>

tal trophoblasts and the pancreatic islets. Br. J. Pharmacol., 134, 1113“36.
Clifton, V. L., Read, M. A., Leitch, I. M. et al. (1994). Corticotropin-releasing hormone-induced
vasodilatation in the human fetal placental circulation. J. Clin. Endocrinol. Metab., 79, 666“9.
59 Placental expression of neurohormones and other neuroactive molecules


Clifton, V. L., Read, M. A., Leitch, I. M. et al. (1995). Corticotropin-releasing hormone-induced
vasodilatation in the human fetal“placental circulation: involvement of the nitric oxide-
cyclic guanosine 3 ,5 -monophosphate-mediated pathway. J. Clin. Endocrinol. Metab., 80,
2888“93.
Clifton, V. L., Read, M. A., Boura, A. L., Robinson, P. J. and Smith, R. (1996). Adrenocor-
ticotropin causes vasodilatation in the human fetal“placental circulation. J. Clin. Endocrinol.
Metab., 81, 1406“10.
Cooper, E. S., Greer, I. A. and Brooks, A. N. (1996). Placental proopiomelanocortin gene expres-
sion, adrenocorticotropin tissue concentrations, and immunostaining increase throughout
gestation and are unaffected by prostaglandins, antiprogestins, or labor. J. Clin. Endocrinol.
Metab., 81, 4462“9.
Corder, R., Turnill, D., Ling, N. and Gaillard, R. C. (1992). Attenuation of corticotropin releasing
factor-induced hypotension in anesthetized rats with the CRF antagonist, alpha-helical
CRF9“41; comparison with effect on ACTH release. Peptides, 13, 1“6.
Curtis, N. E., Ho, P. W., King, R. G. et al. (1997). The expression of parathyroid hormone-related
protein mRNA and immunoreactive protein in human amnion and choriodecidua is
increased at term compared with preterm gestation. J. Endocrinol., 154, 103“12.
Curtis, N. E., King, R. G., Moseley, J. M. et al. (1998). Intrauterine expression of parathyroid
hormone-related protein in normal and pre-eclamptic pregnancies. Placenta, 19, 595“601.
Daifotis, A. G., Weir, E. C., Dreyer, B. E. and Broadus, A. E. (1992). Stretch-induced parathyroid
hormone-related peptide gene expression in the rat uterus. J. Biol. Chem., 267, 23455“8.
Dalle, M., Dauprat-Dalle, P. and Barlet, J. P. (1992). Parathyroid hormone-related peptide
inhibits oxytocin-induced rat uterine contractions in vitro. Arch. Int. Physiol. Biochim.
Biophys., 100, 251“4.
De Geest, K., Thiery, M., Piron-Possuyt, G. and Vanden Driessche, R. (1985). Plasma oxytocin in
human pregnancy and parturition. J. Perinat. Med., 13, 3“13.
Dombroski, R. A., Casey, M. L. and MacDonald, P. C. (1997). 5-alpha-dihydroprogesterone
formation in human placenta from 5alpha-pregnan-3beta/alpha-ol-20-ones and 5-pregnan-
3beta-yl-20-one sulfate. J. Steroid Biochem. Mol. Biol., 63, 155“63.
Dong, Y. L., Fang, L., Kondapaka, S. et al. (1999). Involvement of calcitonin gene-related peptide
in the modulation of human myometrial contractility during pregnancy. J. Clin. Invest., 104,
559“65.
Dvir, R., Golander, A., Jaccard, N. et al. (1995). Amniotic ¬‚uid and plasma levels of parathyroid
hormone-related protein and hormonal modulation of its secretion by amniotic ¬‚uid cells.
Eur. J. Endocrinol., 133, 277“82.
Economides, D., Linton, E., Nicolaides, K. et al. (1987). Relationship between maternal and fetal
corticotrophin-releasing hormone-41 and ACTH levels in human mid-trimester pregnancy.
J. Endocrinol., 114, 497“501.
Ekesbo, R., Alm, P., Ekstrom, P., Lundberg, L. M. and Akerlund, M. (1991). Innervation of the human
uterine artery and contractile responses to neuropeptides. Gynecol. Obstet. Invest., 31, 30“6.
Emly, J. F., Gregory, J., Bowden, S. J. et al. (1994). Immunohistochemical localization of parathy-
roid hormone-related protein (PTHrP) in human term placenta and membranes. Placenta,
15, 653“60.
60 F. Petraglia et al.


Facchinetti, F., Garuti, G., Petraglia, F., Mercantini, F. and Genazzani, A. R. (1990). Changes in
beta-endorphin in fetal membranes and placenta in normal and pathological pregnancies.
Acta Obstet. Gynecol. Scand., 69, 603“7.
Falkay, G. and Kovacs, L. (1994). Expression of two alpha 2-adrenergic receptor subtypes in
human placenta: evidence from direct binding studies. Placenta, 15, 661“8.
Fallgren, B., Edvinsson, L., Ekblad, E. and Ekman, R. (1989). Involvement of perivascular neuro-
peptide Y nerve ¬bres in uterine arterial vasoconstriction in conjunction with pregnancy.
Regul. Pept., 24, 119“30.
Farrugia, W., de Gooyer, T., Rice, G. E., Moseley, J. M. and Wlodek, M. E. (2000). Parathyroid
hormone(1“34) and parathyroid hormone-related protein(1“34) stimulate calcium release
from human syncytiotrophoblast basal membranes via a common receptor. J. Endocrinol.,
166, 689“95.
Ferguson II, J. E., Gorman, J. V., Bruns, D. E. et al. (1992). Abundant expression of parathyroid
hormone-related protein in human amnion and its association with labor. Proc. Natl. Acad.
Sci. USA, 89, 8384“8.
Ferguson II, J. E., Seaner, R. M., Bruns, D. E., Iezzoni, J. C. and Bruns, M. E. (1998). Expression
and speci¬c immunolocalization of the human parathyroid hormone/parathyroid hormone-
related protein receptor in the uteroplacental unit. Am. J. Obstet. Gynecol., 179, 321“9.
Ferrari, A., Petraglia, F. and Gurpide, E. (1995). Corticotropin releasing factor decidualizes
human endometrial stromal cells in vitro. Interaction with progestin. J. Steroid. Biochem. Mol.
Biol., 54, 251“5.
Fiaschi-Taesch, N. M. and Stewart, A. F. (2003). Minireview: parathyroid hormone-related protein
as an intracrine factor “ traf¬cking mechanisms and functional consequences. Endocrinology,
144, 407“11.
Firth, K. F. and Pipkin, F. B. (1989). Human alpha- and beta-calcitonin gene-related peptides are
vasodilators in human chorioic plate vasculature. Am. J. Obstet. Gynecol., 161, 1318“19.
Fiscus, R. R., Zhou, H. L., Wang, X. et al. (1991). Calcitonin gene-related peptide (CGRP)-
induced cyclic AMP, cyclic GMP and vasorelaxant responses in rat thoracic aorta are
antagonized by blockers of endothelium-derived relaxant factor (EDRF). Neuropeptides, 20,
133“43.
Fiscus, R. R., Wang, X. and Hao, H. (1992). hCGRP8“37 antagonizes vasodilations and cAMP
responses to rat CGRP in rat caudal artery. Ann. New York Acad. Sci., 657, 513“15.
Florio, P., Lombardo, M., Gallo, R. et al. (1996). Activin A, corticotropin-releasing factor and
prostaglandin F2 alpha increase immunoreactive oxytocin release from cultured human pla-
cental cells. Placenta, 17, 307“11.
Florio, P., Woods, R. J., Genazzani, A. R., Lowry, P. J. and Petraglia, F. (1997). Changes in amni-
otic ¬‚uid immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein
levels in pregnant women at term and during labor. J. Clin. Endocrinol. Metab., 82, 835“8.
Florio, P., Benedetto, C., Luisi, S. et al. (1999a). Activin A, inhibin A, inhibin B and parturition:
changes of maternal and cord serum levels according to the mode of delivery. Br. J. Obstet.
Gynaecol., 106, 1061“5.
Florio, P., Rivest, S., Reis, F. M. et al. (1999b). Lack of gestational-related changes of urocortin
gene expression in human placenta. Prenat. Neonat. Med., 4, 296“300.
61 Placental expression of neurohormones and other neuroactive molecules


Florio, P., Franchini, A., Reis, F. M. et al. (2000). Human placenta, chorion, amnion and decidua
express different variants of corticotropin-releasing factor receptor messenger RNA. Placenta,
21, 32“7.
Florio, P., Cobellis, L., Luisi, S. et al. (2001a). Changes in inhibins and activin secretion in healthy
and pathological pregnancies. Mol. Cell. Endocrinol., 180, 123“30.
Florio, P., Margutti, A., Apa, R. et al. (2001b). Maternal plasma calcitonin gene-related peptide
levels do not change during labour and are not in¬‚uenced by delivery route. J. Soc. Gynecol.
Invest., 8(3), 165“8.
Florio, P., Ciarmela, P., Luisi, S. et al. (2002a). Pre-eclampsia with fetal growth restriction: pla-
cental and serum activin A and inhibin A levels. Gynecol. Endocrinol., 16, 365“72.
Florio, P., Cobellis, L., Woodman, J. et al. (2002b). Levels of maternal plasma corticotropin-
releasing factor and urocortin during labor. J. Soc. Gynecol. Invest., 9, 233“7.
Florio, P., Mezzesimi, A., Turchetti, V. et al. (2002c). High levels of human chromogranin A in
umbilical cord plasma and amniotic ¬‚uid at parturition. J. Soc. Gynecol. Invest., 9, 32“6.
Florio, P., Severi, F. M., Ciarmela, P. et al. (2002d). Placental stress factors and maternal“fetal
adaptive response: the corticotropin-releasing factor family. Endocrine, 19, 91“102.
Florio, P., Severi, F. M., Cobellis, L. et al. (2002e). Serum activin A and inhibin A. New clinical
markers for hydatidiform mole. Cancer, 94, 2618“22.
Florio, P., Reis, F. M., Pezzani, I. et al. (2003a). The addition of activin A and inhibin A measure-
ment to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia.
Ultrasound Obstet. Gynecol., 21, 165“9.
Florio, P., Severi, F. M., Fiore, G. et al. (2003b). Impaired uterine artery blood ¬‚ow at mid gestation
and low levels of maternal plasma corticotropin-releasing factor. J. Soc. Gynecol. Invest., 10, 294“7.
Foord, S. M. and Craig, R. K. (1987). Isolation and characterisation of a human calcitonin-gene-
related-peptide receptor. Eur. J. Biochem., 170, 373“9.
Fried, G. and Samuelson, U. (1991). Endothelin and neuropeptide Y are vasoconstrictors in
human uterine blood vessels. Am. J. Obstet. Gynecol., 164, 1330“6.
Fried, G., Hokfelt, T., Lundberg, J. M., Terenius, L. and Hamberger, L. (1986). Neuropeptide Y
and noradrenaline in human uterus and myometrium during normal and pre-eclamptic
pregnancy. Hum. Reprod., 1, 359“64.
Frim, D. M., Emanuel, R. L., Robinson, B. G. et al. (1988). Characterization and gestational
regulation of corticotropin-releasing hormone messenger RNA in human placenta. J. Clin.
Invest., 82, 287“92.
Fuchs, A. R., Husslein, P. and Fuchs, F. (1981). Oxytocin and the initiation of human parturition.
II. Stimulation of prostaglandin production in human decidua by oxytocin. Am. J. Obstet.
Gynecol., 141, 694“7.
Fuchs, A. R., Romero, R., Keefe, D. et al. (1991). Oxytocin secretion and human parturition:
pulse frequency and duration increase during spontaneous labor in women. Am. J. Obstet.
Gynecol., 165, 1515“23.
Furchgott, R. F. (1993). Introduction to EDRF research. J. Cardiovasc. Pharmacol., 22, S1“2.
Gagnon, R., Murotsuki, J., Challis, J. R., Fraher, L. and Richardson, B. S. (1997). Fetal sheep
endocrine responses to sustained hypoxemic stress after chronic fetal placental embolization.
Am. J. Physiol., 272, E817“23.
62 F. Petraglia et al.


Gangula, P. R., Supowit, S. C., Wimalawansa, S. J. et al. (1997). Calcitonin gene-related peptide is
a depressor in NG-nitro-L-arginine methyl ester-induced hypertension during pregnancy.
Hypertension, 29, 248“53.
Gangula, P. R., Wimalawansa, S. J. and Yallampalli, C. (2000). Pregnancy and sex steroid hor-
mones enhance circulating calcitonin gene-related peptide concentrations in rats. Hum.
Reprod., 15, 949“53.
Gangula, P. R., Zhao, H., Wimalawansa, S. J. et al. (2001). Pregnancy and steroid hormones
enhance the systemic and regional hemodynamic effects of calcitonin gene-related peptide in
rats. Biol. Reprod., 64, 1776“83.
Gangula, P. R., Dong, Y. L., Wimalawansa, S. J. and Yallampalli, C. (2002). Infusion of pregnant
rats with calcitonin gene-related peptide (CGRP)(8“37), a CGRP receptor antagonist, increases
blood pressure and fetal mortality and decreases fetal growth. Biol. Reprod., 67, 624“9.
Genazzani, A. R., Facchinetti, F. and Parrini, D. (1981). Beta-lipotrophin and beta-endorphin
plasma levels during pregnancy. Clin. Endocrinol. (Oxford), 14, 409“18.
Genazzani, A. R., Petraglia, F., Parrini, D. et al. (1984). Lack of correlation between amniotic ¬‚uid
and maternal plasma contents of beta-endorphin, beta-lipotropin, and adrenocorticotropic
hormone in normal and pathologic pregnancies. Am. J. Obstet. Gynecol., 148, 198“203.
Giles, W. B., McLean, M., Davies, J. J. and Smith, R. (1996). Abnormal umbilical artery Doppler
waveforms and cord blood corticotropin-releasing hormone. Obstet. Gynecol., 87, 107“11.
Glynn, B. P., Wolton, A., Rodriguez-Linares, B., Phaneuf, S. and Linton, E. A. (1998). Urocortin
in pregnancy. Am. J. Obstet. Gynecol., 179, 533“9.
Goebelsmann, U., Abboud, T. K., Hoffman, D.I. and Hung, T. T. (1984). Beta-endorphin in preg-
nancy. Eur. J. Obstet. Gynecol. Reprod. Biol., 17, 77“89.
Gohar, J., Mazor, M. and Leiberman, J. R. (1996). GnRH in pregnancy. Arch. Gynecol. Obstet.,
259, 1“6.
Goland, R. S., Wardlaw, S. L., Blum, M., Tropper, P. J. and Stark, R. I. (1988). Biologically active
corticotropin-releasing hormone in maternal and fetal plasma during pregnancy. Am. J.
Obstet. Gynecol., 159, 884“90.
Goland, R. S., Jozak, S., Warren, W. B. et al. (1993). Elevated levels of umbilical cord plasma
corticotropin-releasing hormone in growth-retarded fetuses. J. Clin. Endocrinol. Metab., 77,
1174“9.
Goland, R. S., Jozak, S. and Conwell, I. (1994). Placental corticotropin-releasing hormone and
the hypercorticolism of pregnancy. Am. J. Obstet. Gynecol., 171, 1287“91.
Goland, R. S., Tropper, P. J., Warren, W. B. et al. (1995). Concentrations of corticotrophin-
releasing hormone in the umbilical-cord blood of pregnancies complicated by pre-eclampsia.
Reprod. Fertil. Dev., 7, 1227“30.
Graf, A. H., Hutter, W., Hacker, G. W. et al. (1996). Localization and distribution of vasoactive
neuropeptides in the human placenta. Placenta, 17, 413“21.
Grammatopoulos, D., Dai, Y., Chen, J. et al. (1998). Human corticotropin-releasing hormone
receptor: differences in subtype expression between pregnant and nonpregnant myometria.
J. Clin. Endocrinol. Metab., 83(1998), 2539“44.
Gray, P. C., Bilezikjian, L. M. and Vale, W. (2002). Antagonism of activin by inhibin and inhibin
receptors: a functional role for betaglycan. Mol. Cell. Endocrinol., 188, 254“60.
63 Placental expression of neurohormones and other neuroactive molecules


Grino, M., Chrousos, G. P. and Margioris, A. N. (1987). The corticotropin releasing hormone
gene is expressed in human placenta. Biochem. Biophys. Res. Commun., 148, 1208“14.
Grove, K. L. and Smith, M. S. (2003). Ontogeny of the hypothalamic neuropeptide Y system.
Physiol. Behav., 79, 47“63.
Halhali,A.,Wimalawansa, S. J., Berentsen,V. et al. (2001). Calcitonin gene- and parathyroid hormone-
related peptides in preeclampsia: effects of magnesium sulfate. Obstet. Gynecol., 97, 893“7.
Hayette, S., Gadoux, M., Martel, S. et al. (1998). FLRG (follistatin-related gene), a new target of
chromosomal rearrangement in malignant blood disorders. Oncogene, 16, 2949“54.
Hermus, A. R., Pieters, G. F., Willemsen, J. J. et al. (1987). Hypotensive effects of ovine and
human corticotrophin-releasing factors in man. Eur. J. Clin. Pharmacol., 31, 531“4.
Hillhouse, E. W. and Grammatopoulos, D. K. (2002). Role of stress peptides during human
pregnancy and labour. Reproduction, 124, 323“9.
Hirota, Y., Anai, T. and Miyakawa, I. (1997). Parathyroid hormone-related protein levels in
maternal and cord blood. Am. J. Obstet. Gynecol., 177, 702“6.
Inoue, T., Kimura, T., Azuma, C. et al. (1994). Structural organization of the human oxytocin
receptor gene. J. Biol. Chem., 269, 32451“6.
Iwashita, M., Kudo, Y., Shinozaki, Y. and Takeda, Y. (1993). Gonadotropin-releasing hormone
increases serum human chorionic gonadotropin in pregnant women. Endocr. J., 40, 539“44.
Jain, V., Shi, S. Q., Vedernikov, Y. P. et al. (1998). In vivo effects of corticotropin-releasing factor
in pregnant rats. Am. J. Obstet. Gynecol., 178, 186“91.
Jain, V., Vedernikov, Y. P., Saade, G. R., Chwalisz, K. and Gar¬eld, R. E. (1999). Endothelium-
dependent- and independent mechanisms of vasorelaxation by corticotropin-releasing factor
in pregnant rat uterine artery. J. Pharmacol. Exp. Ther., 288, 407“13.
Jones, S. A. and Challis, J. R. (1990). Effects of corticotropin-releasing hormone and adrenocor-
ticotropin on prostaglandin output by human placenta and fetal membranes. Gynecol. Obstet.
Invest., 29, 165“8.
Jones, S. A., Brooks, A. N. and Challis, J. R. (1989). Steroids modulate corticotropin-releasing
hormone production in human fetal membranes and placenta. J. Clin. Endocrinol. Metab.,
68, 825“30.
Kang, S. K., Tai, C. J., Cheng, K. W. and Leung, P. C. (2000). Gonadotropin-releasing hormone
activates mitogen-activated protein kinase in human ovarian and placental cells. Mol. Cell.
Endocrinol., 170, 143“51.
Karteris, E., Grammatopoulos, D., Dai, Y. et al. (1998). The human placenta and fetal membranes
express the corticotropin-releasing hormone receptor 1alpha (CRH-1alpha) and the CRH-C
variant receptor. J. Clin. Endocrinol. Metab., 83, 1376“9.
Keelan, J., Song, Y. and France, J. T. (1994). Comparative regulation of inhibin, activin and
human chorionic gonadotropin production by placental trophoblast cells in culture. Placenta,
15, 803“18.
Keelan, J. A., Groome, N. P. and Mitchell, M. D. (1998). Regulation of activin-A production by
human amnion, decidua and placenta in vitro by pro-in¬‚ammatory cytokines. Placenta, 19,
429“34.
Kelly, A. C., Rodgers, A., Dong, K. W. et al. (1991). Gonadotropin-releasing hormone and chorionic
gonadotropin gene expression in human placental development. DNA Cell. Biol., 10, 411“21.
64 F. Petraglia et al.


Kenney, S. P., Kekuda, R., Prasad, P. D. et al. (1999). Cannabinoid receptors and their role in
the regulation of the serotonin transporter in human placenta. Am. J. Obstet. Gynecol., 181,
491“7.
Khatun, S., Kanayama, N., Belayet, H. M. et al. (2000). Increased concentrations of plasma neu-
ropeptide Y in patients with eclampsia and preeclampsia. Am. J. Obstet. Gynecol., 182,
896“900.
Khodr, G. S. and Siler-Khodr, T. M. (1978). Localization of luteinizing hormone-releasing factor
in the human placenta. Fertil. Steril., 29, 523“30.
Khodr, G. S. and Siler-Khodr, T. M. (1980). Placental luteinizing hormone-releasing and its syn-
thesis. Science, 207, 315“17.
Kiang, J. G. and Wei, E. T. (1987). Corticotropin-releasing factor inhibits thermal injury. J.
Pharmacol. Exp. Ther., 243, 517“20.
Kieffer, B. L. and Evans, C. J. (2002). Opioid tolerance-in search of the holy grail. Cell, 108, 587“90.
Kimura, T., Tanizawa, O., Mori, K., Brownstein, M. J. and Okayama, H. (1992). Structure and
expression of a human oxytocin receptor. Nature, 356, 526“9.
Knerr, I., Dachert, C., Beinder, E. et al. (2002). Adrenomedullin, calcitonin gene-related peptide
and their receptors: evidence for a decreased placental mRNA content in preeclampsia and
HELLP syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol., 101, 47“53.
Ko¬nas, G. D., Ko¬nas, A. D., Pyrgerou, M. and Reyes, F. I. (1987). Amniotic ¬‚uid beta-
endorphin levels and labor. Obstet. Gynecol., 69, 945“7.
Korebrits, C., Ramirez, M. M., Watson, L. et al. (1998). Maternal corticotropin-releasing hor-
mone is increased with impending preterm birth. J. Clin. Endocrinol. Metab., 83, 1585“91.
Kraayenbrink, A. A., Dekker, G. A., van Kamp, G. J. and van Geijn, H. P. (1993). Endothelial
vasoactive mediators in preeclampsia. Am. J. Obstet. Gynecol., 169, 160“5.
Kuo, L., Davis, M. J. and Chilian, W. M. (1990). Endothelium-dependent, ¬‚ow-induced dilation
of isolated coronary arterioles. Am. J. Physiol., 259, H1063“70.
Laatikainen, T. J., Raisanen, I. J. and Salminen, K. R. (1988). Corticotropin-releasing hormone in
amniotic ¬‚uid during gestation and labor and in relation to fetal lung maturation. Am. J.
Obstet. Gynecol., 159, 891“5.
Laatikainen, T., Virtanen, T., Kaaja, R. and Salminen-Lappalainen, K. (1991). Corticotropin-
releasing hormone in maternal and cord plasma in pre-eclampsia. Eur. J. Obstet. Gynecol.
Reprod. Biol., 39, 19“24.
Lafond, J., St-Pierre, S., Masse, A., Savard, R. and Simoneau, L. (1997). Calcitonin gene-related
peptide receptor in human placental syncytiotrophoblast brush-border and basal plasma

<<

. 12
( 51 .)



>>